Associated Papers
The Effect of Polymorphisms in SPP1 on Risk of Fracture: A Case-Control Study.
Zhao Y et al.
Medical Science Monitor : International Medical Journal of Experimental and Clinical Research, 2015
Secreted Phosphoprotein 1 Promoter Genetic Variants Are Associated with the Response to Pegylated Interferon α Plus Ribavirin Combination Therapy in Egyptian Patients with Chronic Hepatitis C Virus Infection.
Ali FT et al.
Gut and Liver, 2015
Association of SPP1 promoter variants with hip osteoarthritis susceptibility in Chinese population.
Lv C et al.
Gene, 2015
Association between Osteopontin Promoter Gene Polymorphisms and Haplotypes with Risk of Diabetic Nephropathy.
Cheema BS et al.
Journal of Clinical Medicine, 2015
Association between polymorphisms in osteopontin gene (SPP1) and first episode calcium oxalate urolithiasis.
Safarinejad MR et al.
Urolithiasis, 2013
Osteopontin promoter polymorphisms are associated with susceptibility to gastric cancer.
Lee TY et al.
Journal of Clinical Gastroenterology, 2013
OPN gene polymorphism (Ala250) and lower serum OPN levels are associated with urolithiasis.
Tugcu V et al.
Renal Failure, 2013
The impact of osteopontin promoter polymorphisms on the risk of calcium urolithiasis.
Liu CC et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry, 2010
A functional polymorphism in the Eta-1 promoter is associated with allele specific binding to the transcription factor Sp1 and elevated gene expression.
Hummelshoj T et al.
Molecular Immunology, 2006
Select a paper to view details